Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec;37(17):3521-3522.
doi: 10.1038/s41433-023-02546-4. Epub 2023 May 4.

The NOD audit: Insights into the current state of management for neovascular age-related macular degeneration

Kelvin Yi Chong Teo  1   2
Affiliations
Editorial

The NOD audit: Insights into the current state of management for neovascular age-related macular degeneration

Kelvin Yi Chong Teo. Eye (Lond). 2023 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no competing interests.

Comment on

References

    1. Norridge CG-GM, McKibbin M, Donachie P. First Annual Report of the Age-related Macular Degeneration (AMD) Audit. National Ophthalmology Database Audit, The Royal College of Ophthalmologists. 2023;2–88.
    1. Gillies MC, Walton R, Simpson JM, Arnold JJ, Guymer RH, McAllister IL, et al. Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes. Investig Ophthalmol Vis Sci. 2013;54:5754–60. doi: 10.1167/iovs.13-11993. - DOI - PubMed
    1. Holz FG, Tadayoni R, Beatty S, Berger A, Cereda MG, Cortez R, et al. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol. 2015;99:220–6. doi: 10.1136/bjophthalmol-2014-305327. - DOI - PMC - PubMed
    1. Finger RP, Wiedemann P, Blumhagen F, Pohl K, Holz FG. Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany. Acta Ophthalmol. 2013;91:540–6. doi: 10.1111/j.1755-3768.2012.02493.x. - DOI - PubMed
    1. Cohen SY, Dubois L, Tadayoni R, Fajnkuchen F, Nghiem-Buffet S, Delahaye-Mazza C, et al. Results of one-year’s treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting. Am J Ophthalmol. 2009;148:409–13. doi: 10.1016/j.ajo.2009.04.001. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources